Treatment with MOUNJARO 5 mg once weekly, 10 mg once weekly and 15 mg once weekly for 40 weeks resulted in a statistically significant reduction in HbA1c compared with placebo (see Table 8)
She has reported on countless topics, including sexual wellness, astrology, relationship issues, non-monogamy, mental health, pop culture, and more
One explanation for the rarity of successful weight loss maintenance is that an energy deficit and loss of body fat are both associated with increases in appetite and food intake [5, 6]
While many weight loss medications only target the GLP-1 receptor, tirzepatide is a dual agonist , meaning it targets both GLP-1 and GIP receptors
There is another GLP-1 agonist drug, tirzepatide, which is already being marketed in the United States (theres also already a shortage)